Abstract
INTRODUCTION
During most of the current cardiac pacemaker (PM) and implantable cardioverterdefibrillator (ICD) (i.e. cardiac implantable electronic device (CIED) implantation procedures, cardiac leads are introduced into the venous system via vessels located in the deltopectoral triangle. In such situations, the CIED is placed in a subcutaneous pocket created superficial to the pectoralis major muscle [3, 10] . Creating such a pocket involves tissue traumatization, including damage to myocytes, nerve fibers, and blood vessels, as well as blood extravasation. In the months following the procedure the histological and morphometric parameters of the tissues surrounding the device undergo gradual remodeling into a fibrotic capsule.
The course of CIED implantation procedure as well as the time period after device implantation have, it seems, a significant effect on the extent of tissue remodeling. Moreover, the type of device and leads implanted may affect the nature and rate of structural and morphometric remodeling [1, 9] .
Typically, it is the lead placement inside the heart or vessels that has been analyzed in terms of correlations between fibrous tissue formation and its consequences [5] . Also, a vast majority of literature reports on the histomophology of CIED pockets focus on secondary pacing system infections and their sequelae [11] . The purpose of this paper, however, was to visually present and analyze morphohistologic parameters of CIED pockets in noncomplicated cases. Assessments of the nature of tissue remodeling that had taken place from device implantation to its replacement was presented based on our own observations.
MATERIAL AND METHODS

3
A total of 100 consecutive CIED (17 ICDs and 83 PMs) replacement procedures conducted by the same operating personnel at our center between Jan. 1, 2016, and Oct. 21, 2016 were included in the study (Tab. 1).
These procedures were conducted in 45 females aged 30-98 (mean 80.1±12.6) years (during device replacement) and 55 males aged 41-95 (mean 75.9±11.9) years (during device replacement).
Each procedure had been dictated by the device having reached the elective replacement indication (ERI) phase due to projected battery depletion. Conditions that could affect typical capsule formation, such as: infections, skin lesions, too superficial subcutaneous position of the CIED, etc., were excluded from analysis. Neither did we analyze cases following procedures such as device revision, device up-grade, repair procedures, or other procedures whose timing and/or extent could considerably affect device pocket remodeling.
The analyzed procedures were characterized by normal device follow-up interrogation values from the time of device implantation to its replacement due to ERI.
The device pockets were assessed in terms of their morphometric parameters and the type of "capsule-forming" tissue surrounding the CIED. We distinguished three distinct CIED pocket forms (in terms of their anterior and posterior wall evaluation) based on the following criteria:
1. Group I → "typical" pockets, with a thin and flexible layer of scar tissue forming the anterior (< 0.5 mm) and/or the posterior (< 1.0 mm) wall, 2. Group IIA → pockets with a "typical" anterior wall (see above) and the posterior wall characterized by localized scar tissue thickening (˃ 1-2 mm), 3 . Group IIB → pockets with a "typical" anterior wall (see above) and the (usually entire) posterior wall formed of massive scar tissue (˃ 1-2 mm), 4. Group III → pockets with partial/focal or total wall calcification.
Intraoperative qualification of individual cases into one of these specific groups has been illustrated in the figures of characteristic types of CIED "capsules" included in this paper.
All CIED replacement procedures were conducted via conventional techniques, with local anesthesia. After opening the device pocket, a visual inspection and palpation of its walls were conducted to assess, among others, the positions of the leads with respect to the device itself. After ascertaining normal lead function, supported by device interrogation 4 findings, a new device was inserted and connected. In order to avoid any potential damage to the lead insulation layer during tissue dissection, in some cases a control fluoroscopy (posteroanterior view; OEC 9900 Elite fluoroscopy system, GE) was conducted immediately prior to the procedure.
In patients that were representative for the selected group types, biopsy samples (up to 2 x 4 mm) of the pocket wall were collected from the site of its incision, towards the end of the procedure, prior to device pocket closure. Digital microscopy imges of collected samples were recorded and linear measurements were made off-line with respect to a 1/10mm (100 μm) micrometric reference scale (Fig. 1C) .
The tissue samples were fixed in 4% buffered formalin, embedded in paraffin blocks, and sectioned into 4-micrometer sections, deparaffinized and stained with hematoxylin-eosin This study had been approved by the Institutional Review Board. -Group III: 7% of capsules were distinctly different from the other capsule types: they were characterized by a hard, calcified structure, closely adherent to the CIED, which usually had to be manually broken during device replacement, and whose edges were sharp. Among the cases analyzed here there were those with the entire device capsule being calcified, as well as those with focal wall calcifications. Examples: Fig. 5 .
RESULTS
Device
No evidence of capsule calcification was observed in PM patients under 80 years of age. Group III capsule characteristics were observed in 7 octogenarians (mean age 88.5 years); these cases constituted 14% of all patients in their 80s (P=0.019). The presence of pocket calcification also correlated with the "age" of CIED pockets (˃ 13 years; mean 13.5 ± 0.8).
Histopathological evaluation showed capsule variety ( Fig. 1-3) , which was seen in a vast majority of Group I and II patients. Capsule wall structure was cell-poor fibrous connective tissue with mononuclear cells and a large number of vessels, especially within fibrous connective tissue. In Group III, we observed focal (Fig. 4 C, D) /planar (Fig. 5, 6) hyalinization of the fibrous tissue with calcification along the fibers. The components of cardiac lead insulation (polyurethane, silicon rubber) are considered to be compatible with the surrounding biological environment, which most likely eliminates them as a potential cause of the localized scarring observed in this study [9] .
Pacemaker capsule calcification, in this study observed in patients in their 80s and 90s, with an over 13-year-old device pocket. Capsule calcification was not observed in the case of ICD pockets. However, the latter type of CIEDs was found in younger patients with shorter time periods to device replacement, for reasons including indications for this type of electrotherapy and the devices' individual use of power.
Formation of massive scar tissue in the pocket walls and/or wall calcification make it more difficult to isolate leads during device removal as well as to implant new leads during device up-date procedures [2, 8] . This mechanism of potential lead insulation damage becomes especially important in patients without an intrinsic rhythm, in whom loss of pacing effectiveness may become immediately life-threatening.
Limitations of the study
For the purposes of this manuscript, the sample size was limited to 100 cases, which the authors believe to be a representative sample for this type of analysis. As the most commonly observed anterior and posterior capsule wall thickness was below 0.5 and 1.0 mm, 8 respectively, these values were selected as threshold values differentiating the "normal" and "thickened" scar tissue layers.
CONCLUSIONS
Morphometric parameters of a formed CIED capsule are significantly affected by spatial relations between the device and the extravascular cardiac lead segments, where lead loop migration underneath the device may facilitate scar tissue formation in the posterior wall of the device pocket.
The cases of pocket calcification discovered in our patients showed this phenomenon occurring exclusively in the oldest patient group in conjunction with "old" device pockets, although calcification was not present in all such cases. 
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